Virtual Medicinal Product (VMP)
-
Epoprostenol 500microgram powder (pH12) for solution for infusion vials
Name Details
Current Name
Epoprostenol 500microgram powder (pH12) for solution for infusion vials
|
Start Date
26-11-2018
|
End Date
|
Previous Name
Epoprostenol 500microgram powder for solution for infusion vials
|
Start Date
27-06-2013
|
End Date
25-11-2018
|
|
Abbreviated Name
Epoprostenol 500microgram (pH12) inf vials
|
Start Date
07-01-2020
|
|
Epoprostenol 500microgram inf vials |
Previous Start Date
27-06-2013
|
Previous End Date
06-01-2020
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
B01AC09
BNF |
Current BNF
02080100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02080100
|
Start Date
30-10-2014
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
22648411000001105 |
27-06-2013 |
|
VMP Ingredients
Name
Epoprostenol sodium
Basis of strength description
Based on Base Substance
BOSS
Epoprostenol
Strength and UOM (Nmr)
500.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Epoprostenol
-
VMP
(Current) Epoprostenol 500microgram powder (pH...
Virtual Medicinal Product Pack (VMPP) Information